跳至主要内容
临床试验/NCT01470638
NCT01470638已完成不适用

Analyzes of Cerebrospinal Fluid in Autoimmune Systemic Diseases

Göteborg University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome

研究概览

简要总结

The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

详细描述

The study aims to correlate levels of Flt3-ligand in CSF and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fulfill the ACR-criteria for primary Sjogrens syndrome,
  • age above 18 years old

排除标准

  • other CNS-disease

结局指标

主要结局

Correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome

时间窗: June 2009 - June 2015

次要结局

未报告次要终点

研究者

发起方
Göteborg University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study of Flt3-Ligand Levels in Sjögrens Syndrome | 临床试验